arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Keros Therapeutics, Inc.

KROS Health Care Biotechnology: Pharmaceutical Preparations
$10.21
Today
as of Jul 22, 16:50 ET
Last 30 days +0.59% Jun 12 → Jul 22
$9.87 $10.45 $11.03 $11.61 $12.19 Jun 12 Jun 22 Jun 29 Jul 08 Jul 15 Jul 22
Open
$10.78
High
$10.84
Low
$10.24
Volume
$139,590
Avg Vol
$573,569
Mkt Cap
$210M
P/E (TTM)
Beta
52w High
$22.55
52w Low
$9.79
Div Yield
Shares Out
$20M

Recent Press Releases & News last 60 days · 2 items

Overview

52-week range
$9.79
$23
3% of range
Avg surprise (last 3)
+12,101%
Avg reaction (last 2)
-6.9%
0% positive
Latest IV / EM
32%
EM ±7.3% · $10 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.41$-0.15$1.11$2.36$3.62 Actual $-1.27Actual $-1.33Actual $-1.21Actual $-1.25Actual $-1.41Actual $3.62Est $-0.01Actual $-0.76Est $-1.14Actual $-0.18Actual $-1.21Est $-0.92 JunSepMarJunSepMar/2025Jun/2025SepMar/2026
Revenue vs Net Income Revenue Net income
$-53M$16M$84M$153M$222M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-1.21 $-0.92 -31.5% -133.4% -8.3% earnings
Tue Sep 30, 2025Sep 2025 $-0.18 financials
Wed Aug 6, 2025Jun/2025 $-0.76 $-1.14 +33.3% earnings
Tue May 6, 2025Mar/2025 $3.62 $-0.01 +36,300% -5.5% earnings
Mon Sep 30, 2024Sep 2024 $-1.41 financials
Sun Jun 30, 2024Jun 2024 $-1.25 financials
Sun Mar 31, 2024Mar 2024 $-1.21 financials
Sat Sep 30, 2023Sep 2023 $-1.33 financials
Fri Jun 30, 2023Jun 2023 $-1.27 financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Aug 5, 2026Jun/2026OTHER -$1.25-$0.76 -64.5%

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$32,000$14M$18M$211M$0$0
Cost of revenue
Gross profit
Operating income$-26M$-15M$-40M$152M$-59M$-50M
Net income$-24M$-7M$-31M$148M$-53M$-45M
EPS (diluted)$-1.21$-0.18$-0.76$3.62$-1.41$-1.25

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$281M$287M$693M$690M$721M$560M$531M$406M
Inventory
Total current assets$291M$315M$719M$733M$760M$589M$552M$433M
Total assets$312M$338M$743M$757M$785M$616M$579M$455M
Long-term debt
Total liabilities$27M$35M$39M$50M$56M$44M$46M$34M
Total equity$286M$303M$704M$707M$729M$572M$533M$421M

Implied volatility — last 90 days

19%181%343%505%667% Jun 07 — IV 350% · EM ±48.5%Jun 08 — IV 45% · EM ±6.0%Jun 09 — IV 44% · EM ±5.5%Jun 10 — IV 55% · EM ±6.5%Jun 19 — IV 210% · EM ±46.5%Jun 22 — IV 218% · EM ±45.5%Jun 23 — IV 269% · EM ±55.0%Jun 24 — IV 123% · EM ±24.7%Jun 25 — IV 25% · EM ±4.8%Jun 26 — IV 19% · EM ±3.6%Jun 29 — IV 137% · EM ±24.2%Jun 30 — IV 170% · EM ±29.2%Jul 09 — IV 165% · EM ±19.5%Jul 14 — IV 667% · EM ±48.2%Jul 20 — IV 28% · EM ±6.6%Jul 21 — IV 26% · EM ±6.1%Jul 22 — IV 32% · EM ±7.3%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.